Novo Nordisk saw price pressure for its GLP-1 drugs Ozempic and Wegovy. Investors want to know how Eli Lilly’s Zepbound performed.
Citi’s post-pullback stock shopping list: Where to go after market sell-off
Investors looking to sift through the sell-off should look for stocks that can withstand an economic shakeout, according to Citi.
Tempted to buy some beaten-up stocks? Look for these chart signals first
David Keller breaks down the chart in Salesforce and gives key tips for buying beaten-up stocks.
Gold could end up being the best investment of 2024
The gold trade has held up better than riskier asset classes in August and could benefit from Fed rate cuts in the months ahead.
Warren Buffett now owns more T-bills than the Federal Reserve
The Omaha-based conglomerate held $234.6 billion in short-term investments in Treasury bills by the end of the second quarter.
Bitcoin proving it’s not quite the ‘digital gold’ many traders were hoping for it to become
The market chaos this week has revived the debate about how to value bitcoin: Is it a risk asset or a hedge?
Using options to generate income on Nvidia’s volatility and maybe get long the stock for cheap
Tony Zhang breaks down how to use the market volatility to your advantage.
Here are Wednesday’s biggest analyst calls of the day: Nvidia, Apple, Target, Super Micro & more
Here are Wednesday’s biggest calls on Wall Street.
These stocks offer investors stable growth in a slowing economy and turbulent market, Goldman says
Goldman Sachs shared a basket of names that may hold up amid fears of a potential recession hitting the U.S. economy.
Wednesday’s analyst calls: Super Micro Computer earnings reaction, AMD a top pick
Two names tied to the artificial intelligence trade were among the stocks being talked about by analysts on Wednesday.